Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its price target raised by analysts at HC Wainwright from $24.00 to $26.00. They now have a "buy" rating on the stock.
Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update
Catalyst Pharmaceutical (CPRX) Reports Next Week: Wall Street Expects Earnings Growth [Yahoo! Finance]